Movano Inc. (MOVE)
| Previous close | 0.4690 |
| Open | 0.4690 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.4689 - 0.4690 |
| 52-week range | 0.3700 - 1.5000 |
| Volume | |
| Avg. volume | 233,891 |
| Market cap | 46.058M |
| Beta (5Y monthly) | 0.29 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.6300 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireMovano Health Closes $24 Million Private Placement
Movano Health (Nasdaq: MOVE), a pioneer in health technology, has closed on a $24.1 million private placement, totaling 45.3 million units, with each unit consisting of one share of the Company's common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase a share of common stock, to a select group of investors that includes a tier-one multi-billion dollar medical device company, institutional and accredited investors, and members of the Company's management team and board of
- PR Newswire
Movano Health Reports 2023 Financial Results and Provides Business Update
Movano Health (Nasdaq: MOVE), a pioneer in health technology, reported fourth quarter and year end 2023 results and provided a business update.
- PR Newswire
Movano Health Announces $24 Million Private Placement
Movano Health (Nasdaq: MOVE), a pioneer in health technology, today has agreed to sell approximately 45 million units in a $24 million private placement, with each unit consisting of one share of the Company's common stock (or pre-funded warrant in lieu thereof) and one warrant to purchase a share of common stock, to a select group of investors that includes a tier-one multi-billion dollar medical device company, institutional and accredited investors, and members of the Company's management tea
